Bharglob 16.5% Injection 2ml

Are allergic or hypersensitive to any of the other ingredients of this medicine Have developed antibodies against immunoglobulins of the type IgA in your blood Suffer from hyperprolinaemia type I or II (a genetic disorder causing high levels of the amino acid proline in the blood) Have an underlying inflammatory condition Have diabetes Have low blood volume (hypovolemia) and problems with your blood vessels (vascular diseases) Have an increased tendency for blood clotting (thrombophilia or thrombotic episodes) Have a disease or a condition which causes your blood to thicken (hyper viscous blood) Have or had heart or kidney problems

This medicine is usually administered by your doctor or nurse It is given solely for the infusion into a vein (intravenous infusion) If you receive more BHARGLOB 16.5% If you think you have given too much of this medicine, contact your doctor or go to nearest hospital Symptoms of overdose: blood may become too thick (hyperviscous), which might increase the risk of developing blood clots

Sudden fall in blood pressure, dizziness, faint on standing, cold in the hands and feet, sense an abnormal heartbeat or chest pain, or have blurred vision Formation of blood clots Myocardial infarction Muscle weakness Painful respiration due to transfusion related lung injury Temporary non-infectious meningitis (reversible aseptic meningitis) Stiff neck, fever, nausea, vomiting, headache, abnormal sensitivity to light, mental disturbances Increase in blood creatinine level Proteinuria Acute renal failure Transient decrease in red blood cells, anaemia, leukopenia, anisocytosis (including microcytosis)

Vaccinations like measles, mumps, rubella and varicella

Keep this medicine out of reach of children Store in a refrigerator at 2-8°C